van der Knaap, Ronald <br/><br/>
Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.  [electronic resource] 

 -  Cancer  Feb 2008 
 - 748-57 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.23215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Cohort Studies<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Humans<br/>Incidence<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutagenesis, Insertional<br/>Neoplasms--drug therapy<br/>Netherlands--epidemiology<br/>Peptidyl-Dipeptidase A--genetics<br/>Polymorphism, Genetic<br/>Proportional Hazards Models<br/>Prostatic Neoplasms--drug therapy<br/>Renin-Angiotensin System--drug effects<br/>Risk Assessment--statistics & numerical data<br/>Sequence Deletion